Mualliflar

  • Шомуротов Ш.А., Филатова А.В., Мамадрахимов А.А., Джурабаев Дж.Т., Тураев А.С.
  • Асадуллаев М.М.

##semicolon##

атеросклероз, бляшка, таргетные препараты, молекулярные мишени, наночастицы, липосомы.

##submission.citations##

Wang J. et al. Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Atherosclerosis // Adv. Sci. – 2022. – Vol. 9 (24). – P. 2202416. DOI: 10.1002/advs.202202416.

Zhou F., et al. Spherical nucleic acids targeting LOX-1 mitigate oxidative stress in atherosclerosis // ACS Nano. – 2022. – Vol. 16, №2. – P. 1811-1825. DOI: 10.1021/acsnano. 1c10154.

Chen Y. et al. VCAM-1 antibody functionalized nanoparticles for targeted delivery of colchicine in atherosclerosis // Theranostics. – 2023. – Vol. 13, №3. – P. 1020-1032. DOI: 10.7150/thno.79356.

Li J. et al. Dual-responsive Methotrexate-HSA liposomes for stabilizing atherosclerotic plaque // Int. J. Nanomedicine. – 2025. – Vol. 20. – P. 309-321. DOI: 10.2147/IJN. S502850.

Millar S.A. et al. Modulating Plaque Inflammation via Targeted mRNA Nanoparticles // Nature. – 2023. – Vol. 616 (7956). – P. 450-456. PMID: 37669404.

Zhang Y. et al. Anti-CD47 nanoparticle platform enhances efferocytosis and plaque stabilization in atherosclerosis // Biomaterials. – 2023. – Vol. 293. – Р. 121935. DOI: 10.1016/j.biomaterials.2022.121935.

Tang J. et al. Platelet membrane-coated nanoparticles for targeted atherosclerosis therapy // Nano Letters. – 2023. – Vol. 23, №1. – P. 88-97. DOI: 10.1021/acs.nanolett.2c04213.